Spots Global Cancer Trial Database for Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT
Official Title: Clinical Validation of a Fractional Administration Device for Holmium-166 Microspheres During Selective Internal Radiation Therapy in Patients With Liver Tumours
Study ID: NCT05183776
Interventions
Study Description
Brief Summary: To investigate the in vivo performance and safety of a novel medical device for the injection of holmium-166 microspheres during radioembolization. The main potential advantage of this device is that it allows for injection of a during treatment determined dose, which is not possible with the current administration tool.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
RadboudUMC, Nijmegen, , Netherlands
Contact Details
Name: Frank Nijsen, PhD.
Affiliation: Associate professor
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
